Summary of the ISHLT Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update
Published 13 March 2026
Jon Kobashigawa, MD; Andreas Zuckermann, MD; Luciano Potena, MD, PhD; Abbas Ardehalis, MD; Marius Berman, MD; Patricia Chang, MD, MHS; Fardad Esmailian, MD; Maryjane Farr, MD, MSc; Shelley Hall, MD; Eileen Hsich, MD; Kiran Khush, MD, MAS; Michelle Kittleson, MD, PhD; Pascal Leprince, MD, PhD; Yosef Manla, MD; Sofia Martin-Suarez, MD, PhD; Yasbanoo Moayedi, MD, MHSc; Javier Segocia-Cubero, MD, PhD; Ashish Shah, MD; John Trahanas, MD; Peter MacDonald, MD, PhD; on behalf of the Consensus Conference Participatns
J Heart Lung Transplant. March 2026.
Over the past decade, there has been a growing understanding of primary graft dysfunction incidence, presentation, risk factors, biomarkers, potential underlying pathophysiology, and prevention, including the use of advanced organ procurement and preservation technologies, management strategies, and outcomes. However, current practices remain variable, attributable to a lack of objective data and largely influenced by center-specific practices.
The 2024 ISHLT Consensus Conference on Primary Graft Dysfunction took
place in Prague on 9 April, 2024, and was designed to provide a forum for in-depth discussions among leading experts in the field, and represented a collaborative
multidisciplinary effort by experts in cardiac transplantation worldwide
to update current definitions and classifications of graft dysfunction,
enrich the heart transplant community understanding of its risk factors
and biomarkers, delve into potential prevention and management
strategies, and unwind primary graft dysfunction overlap with vasoplegia.
This resulting document aims to provide a more standardized pathway for the prevention, diagnosis, and management of graft dysfunction after heart transplantation and pave the way for future studies.
Read at JHLTTop Takeaways
Click to view larger image and all top takeaways.

Related Guidlines
-
The 2016 ISHLT Listing Criteria for Heart Transplantation: A 10-year Update
-
HFSA/SAEM/ISHLT Clinical Expert Consensus Document on the Emergency Management of Patients with Ventricular Assist Devices
-
Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection
-
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
-
ISHLT Statement on Vaccines in Transplant Recipients

